Federal Circuit Reverses Summary Judgment of Invalidity for Patent Covering Prescription Sorting Machines

Aug 30, 2016

Reading Time : 1 min

The patent at issue, U.S. Patent No. 6,910,601, discussed a “collating unit,” which corrals prescription containers after they have been filled with a prescription by an automatic dispensing system. The asserted claims were directed to such a collating unit, but did not recite a limitation for how the containers were sorted and stored. The district court determined that the ’601 patent disclosed only a collating unit that used patient-specific information for sorting and storing the containers. Citing Gentry Gallery and ICU Medical, the district court ruled that the claims were invalid for being broader than the disclosure.

The Federal Circuit disagreed. That court drew a distinction between the disclosures in the ’601 patent and the patents involved in Gentry Gallery and ICU Medical. In Gentry Gallery and ICU Medical, “the specifications clearly limited the scope of the claims in ways that the claims clearly did not.” But, even though “much of the ’601 patent’s specification focuse[d] on” a type of embodiment using patient-specific information, the Federal Circuit held that the ’601 patent was not so limited. Rather, the specification disclosed other problems which the invention could solve by using different types of information, such as the type of medication or the date the prescription is filled. Additionally, the Federal Circuit found support in the originally-filed claims. As part of the disclosure, these claims supported the broader invention because they, too, were not limited to embodiments relying on patient-specific information.

ScriptPro LLC v. Innovation Assocs., Inc., No. 2015-1565, 2016 WL 4269920 (Fed. Cir. Aug. 15, 2016).

[Moore (opinion), Taranto, and Hughes]

Share This Insight

Previous Entries

IP Newsflash

February 27, 2026

The USPTO Director denied a patent owner’s request for discretionary denial of two inter partes review (IPR) petitions, citing the petitioner’s “well-settled expectation” that it would not be accused of infringing the two challenged patents. The Director’s conclusion was based on the petitioner’s decade-long business relationship with the original owner of the challenged patents.

...

Read More

IP Newsflash

February 24, 2026

The Southern District of Florida recently dismissed a complaint without prejudice because the allegations used a form of “shotgun pleading.” The court explained that a shotgun pleading includes those where every count incorporates every preceding paragraph into each cause of action, and that dismissal of such pleadings was required under Eleventh Circuit precedent.

...

Read More

IP Newsflash

February 20, 2026

The Federal Circuit recently addressed whether the PTO must conduct notice‑and‑comment rulemaking before issuing instructions that guide how the Board should exercise discretion at the institution stage of IPRs. The court held that no such rulemaking is required. Instructions to the Board regarding its use of the Director’s delegated discretionary authority not to institute review are merely general statements of policy exempt from notice-and-comment rulemaking.  

...

Read More

IP Newsflash

February 18, 2026

The District Court for the District of Delaware recently invalidated claims directed to a panoramic objective lens for lack of enablement, holding the claims impermissibly recited a single element in means‑plus‑function form. Under § 112, ¶ 6, “[a]n element in a claim for a combination may be expressed as a means or step for performing a specified function….” By its plain terms, the statute permits means‑plus‑function claiming only in the context of a “combination.” In other words, a claim may not consist solely of a single means‑plus‑function element. Claims drafted as a single means are invalid for lack of enablement as a matter of law.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.